Updates to the HTA Review: consultation 2 survey

6 February 2024 - Access to the HTA Review Consultation 2 online survey is now available on the Office of ...

Read more →

Almost one-third of adult Australians say they’re unlikely to get COVID vaccination: survey

19 May 2021 - Almost one-third of adult Australians say they are unlikely to be vaccinated against COVID-19 in a ...

Read more →

2019 oncology drugs in pipeline — survey

14 December 2018 - pCODR is again undertaking its periodic survey to facilitate consistent and systematic data collection from participating ...

Read more →

Differentiation of health-related quality of life outcomes between five disease areas: results from an international survey of patients

25 September 2018 - Health-related quality of life data generated by generic, preference-based instruments are highly demanded in health policy decision ...

Read more →

Innovative pharmaceutical pricing agreements in five European markets: A survey of stakeholder attitudes and experience

31 May 2018 - Innovative pricing agreements for medicines have been used in European markets for more than 20 years, ...

Read more →

Is “end of life” a special case? Connecting Q with survey methods to measure societal support for views on the value of life-extending treatments

19 January 2018 - Preference elicitation studies reporting societal views on the relative value of end-of-life treatments have produced equivocal results.  ...

Read more →

Payers’ experiences with confidential pharmaceutical price discounts: a survey of public and statutory health systems in North America, Europe, and Australasia

1 April 2017 - Institutional payers for pharmaceuticals worldwide appear to be increasingly negotiating confidential discounts off of the official list ...

Read more →